Baczkó I - Search Results

1

Altered expression of genes for Kir ion channels in dilated cardiomyopathy.

Szuts V, Ménesi D, Varga-Orvos Z, Zvara Á, Houshmand N, Bitay M, Bogáts G, Virág L, Baczkó I, Szalontai B, Geramipoor A, Cotella D, Wettwer E, Ravens U, Deák F, Puskás LG, Papp JG, Kiss I, Varró A, Jost N. Szuts V, et al. Among authors: baczko i. Can J Physiol Pharmacol. 2013 Aug;91(8):648-56. doi: 10.1139/cjpp-2012-0413. Epub 2013 Mar 4. Can J Physiol Pharmacol. 2013. PMID: 23889090

2

Disease- and sex-specific differences in patients with heart valve disease: a proteome study.

Nordmeyer S, Kraus M, Ziehm M, Kirchner M, Schafstedde M, Kelm M, Niquet S, Stephen MM, Baczko I, Knosalla C, Schapranow MP, Dittmar G, Gotthardt M, Falcke M, Regitz-Zagrosek V, Kuehne T, Mertins P. Nordmeyer S, et al. Among authors: baczko i. Life Sci Alliance. 2023 Jan 10;6(3):e202201411. doi: 10.26508/lsa.202201411. Print 2023 Mar. Life Sci Alliance. 2023. PMID: 36627164 Free PMC article.

3

ATP-sensitive potassium channel modulators: both pinacidil and glibenclamide produce antiarrhythmic activity during acute myocardial infarction in conscious rats.

Leprán I, Baczkó I, Varró A, Papp JG. Leprán I, et al. Among authors: baczko i. J Pharmacol Exp Ther. 1996 Jun;277(3):1215-20. J Pharmacol Exp Ther. 1996. PMID: 8667181

4

Influence of anesthetics on the incidence of reperfusion-induced arrhythmias and sudden death in rats.

Baczkó I, Leprán I, Papp JG. Baczkó I, et al. J Cardiovasc Pharmacol. 1997 Feb;29(2):196-201. doi: 10.1097/00005344-199702000-00007. J Cardiovasc Pharmacol. 1997. PMID: 9057068

5

KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.

Baczkó I, Leprán I, Papp JG. Baczkó I, et al. Eur J Pharmacol. 1997 Apr 11;324(1):77-83. doi: 10.1016/s0014-2999(97)00064-2. Eur J Pharmacol. 1997. PMID: 9137916

6

Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats.

El-Reyani NE, Bozdogan O, Baczkó I, Leprán I, Papp JG. El-Reyani NE, et al. Among authors: baczko i. Eur J Pharmacol. 1999 Jan 22;365(2-3):187-92. doi: 10.1016/s0014-2999(98)00866-8. Eur J Pharmacol. 1999. PMID: 9988102

7

Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.

Baczkó I, El-Reyani NE, Farkas A, Virág L, Iost N, Leprán I, Mátyus P, Varró A, Papp JG. Baczkó I, et al. Eur J Pharmacol. 2000 Sep 15;404(1-2):181-90. doi: 10.1016/s0014-2999(00)00591-4. Eur J Pharmacol. 2000. PMID: 10980278

8

Effect of glibenclamide and glimepiride treatment on the development of myocardial infarction in rats.

El-Reyani NE, Baczkó I, Leprán I, Papp JG. El-Reyani NE, et al. Among authors: baczko i. Acta Physiol Hung. 2000;87(2):173-84. Acta Physiol Hung. 2000. PMID: 11205966

9

Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.

Lengyel C, Varró A, Tábori K, Papp JG, Baczkó I. Lengyel C, et al. Among authors: baczko i. Br J Pharmacol. 2007 Aug;151(7):941-51. doi: 10.1038/sj.bjp.0707297. Epub 2007 May 29. Br J Pharmacol. 2007. PMID: 17533421 Free PMC article.

10

Contribution of I Kr and I K1 to ventricular repolarization in canine and human myocytes: is there any influence of action potential duration?

Jost N, Acsai K, Horváth B, Bányász T, Baczkó I, Bitay M, Bogáts G, Nánási PP. Jost N, et al. Among authors: baczko i. Basic Res Cardiol. 2009 Jan;104(1):33-41. doi: 10.1007/s00395-008-0730-3. Epub 2008 Jul 5. Basic Res Cardiol. 2009. PMID: 18604626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters